ARGNF:OTCMKTS
argenx SE
790,15 $
0,00%
(0,00) 1D
13 հոկ, 10:39:58 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
51,51 մլրդ
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 $
52-wk low
708,72 $
Beta
0,46
Shares outstanding
62,89 մլն
No. of employees
2 հզր
Mkt. cap
51,51 մլրդ
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 $
52-wk low
708,72 $
Beta
0,46
Shares outstanding
62,89 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
11 ժամ առաջ
argenx reports trial results: what it means for argenx stock
TipRanks
·
22 ժամ առաջ
Argenx Stock Stumbles As Trial Failure Haunts Rally
Yahoo Finance
·
1 օր առաջ
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Simply Wall Street
·
3 օր առաջ
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE